Pharmafile Logo
Pharmafocus logo
Advanced Search

simtuzumab

Showing 1 posts of 1 posts found.

Gilead logo

Gilead terminates Phase II simtuzumab IPF study

January 6, 2016
Research and Development Gilead, IPF, idiopathic pulmonary fibrosis, simtuzumab

Gilead Sciences has announced the termination of its Phase II clinical study of the investigational monoclonal antibody simtuzumab in patients …

News
The Gateway to Local Adoption Series

Latest content

Weber is new CMO at Sensorion

October 28, 2026

Charity commits £800,000 to AI research into late breast cancer recurrence

October 28, 2026

AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over

October 27, 2026

Acumetis CEO Herspiegel steps down as Burden assumes role

October 27, 2026

Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia

October 27, 2026